April 26U.S. Considers Concessions on Drug Protections in China Talks, Sources Say
The Trump administration may concede to a Chinese proposal that would give less protection for U.S. pharmaceutical products than they receive at home, according to people familiar with the matter, a move that could draw opposition from the American drug industry.
April 26California Leads On Prescription Drugs
California regularly portrays itself as a national trendsetter on political issues, and Gov. Gavin Newsom is claiming that title on prescription drugs.
April 26Klobuchar Wants To Stop ‘Pay-For-Delay’ Deals That Keep Drug Prices High
Washington’s recent fixation with lowering drug costs has introduced Americans to once-insider terms like “pharmacy benefit managers” and “list prices.”
April 26Biden Foundation Suspends Operations, Effective Immediately
The Biden Foundation, created in 2017 by former Vice President Joe Biden and Dr. Jill Biden, announced Thursday that it would suspend operations effective immediately, just hours after Joe Biden formally launched his campaign for the 2020 Democratic presidential nomination.
April 26Arkansas Sues 3 Drug Distributors Over Opioid Crisis
Arkansas' attorney general on Thursday sued three drug distributors for their alleged role in the opioid crisis, claiming the companies failed to monitor and report suspicious shipments of opioids into the state.
April 25PBM Horror Stories V, Biosimilars Position Statement, Are You Being Forced to White/Brown Bag?
PBM Horror Stories Volume V: Dangerous Health Care Middlemen & Bureaucracies To continue raising awareness of the patient impact of pharmacy benefit manager (PBM) abuses on patients with cancer COA recently released the fifth volume in its series of papers documenting real-life PBM horror stories from patients and oncology professionals across the country. The
COA supports a wide variety of initiatives for community oncology practices, professionals, and patient advocates. We give community
oncologists and hematologists a powerful voice to help drive policymaking, innovation, and reform of the cancer care system.